Gupta, Deepak K.

Heart Disease and Stroke Statistics—2021 Update: A Report From the American Heart Association

Virani, S. S., Alonso, A., Aparicio, H. J., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Cheng, S., Delling, F. N., et al. (2021) · Circulation

Cardiovascular Health and Risk FactorsHealthcare Systems and Public Health

Cited by 5,784

Prospective Study of Cardiac Events During Proteasome Inhibitor Therapy for Relapsed Multiple Myeloma

Cornell, R. F., Ky, B., Weiss, B. M., Dahm, C. N., Gupta, D. K., Du, L., Carver, J. R., Cohen, A. D., Engelhardt, B. G., Garfall, A. L., et al. (2019) · Journal of Clinical Oncology

Chemotherapy-induced cardiotoxicity and mitigationMultiple Myeloma Research and Treatments

Cited by 198

Neighborhood Deprivation Predicts Heart Failure Risk in a Low-Income Population of Blacks and Whites in the Southeastern United States

Akwo, E. A., Kabagambe, E. K., Harrell, F. E., Blot, W. J., Bachmann, J. M., Wang, T. J., Gupta, D. K., & Lipworth, L. (2018) · Circulation: Cardiovascular Quality and Outcomes

Health disparities and outcomesHeart Failure Treatment and Management

Cited by 143

Risk-based primary prevention of heart failure: a scientific statement from the American Heart Association

Khan, S. S., Breathett, K., Braun, L. T., Chow, S. L., Gupta, D. K., Lekavich, C., Lloyd-Jones, D. M., Ndumele, C. E., Rodriguez, C. J., Allen, L. A., et al. (2025) · Circulation

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 75

Effect of dapagliflozin in DAPA-HF according to background glucose-lowering therapy

Docherty, K. F., Jhund, P. S., Bengtsson, O., DeMets, D. L., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Langkilde, A. M., Martinez, F. A., Sabatine, M. S., et al. (2020) · Diabetes Care

Diabetes Treatment and ManagementHeart Failure Treatment and Management

Cited by 44